PL2215480T3 - Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń - Google Patents

Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń

Info

Publication number
PL2215480T3
PL2215480T3 PL08855400T PL08855400T PL2215480T3 PL 2215480 T3 PL2215480 T3 PL 2215480T3 PL 08855400 T PL08855400 T PL 08855400T PL 08855400 T PL08855400 T PL 08855400T PL 2215480 T3 PL2215480 T3 PL 2215480T3
Authority
PL
Poland
Prior art keywords
diagnostic
diseases
therapeutic tools
vascular function
altering vascular
Prior art date
Application number
PL08855400T
Other languages
English (en)
Inventor
Hans Vink
Erik Sjoerd Gerard Stroes
Original Assignee
Univ Maastricht
Acad Ziekenhuis Maastricht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maastricht, Acad Ziekenhuis Maastricht filed Critical Univ Maastricht
Publication of PL2215480T3 publication Critical patent/PL2215480T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/525Tumor necrosis factor [TNF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50Lipopolysaccharides; LPS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/323Arteriosclerosis, Stenosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/328Vasculitis, i.e. inflammation of blood vessels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08855400T 2007-11-30 2008-12-01 Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń PL2215480T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122043 2007-11-30
EP08855400A EP2215480B1 (en) 2007-11-30 2008-12-01 Diagnostic and therapeutic tools for diseases altering vascular function
PCT/EP2008/066524 WO2009068685A1 (en) 2007-11-30 2008-12-01 Diagnostic and therapeutic tools for diseases altering vascular function

Publications (1)

Publication Number Publication Date
PL2215480T3 true PL2215480T3 (pl) 2012-09-28

Family

ID=39247715

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08855400T PL2215480T3 (pl) 2007-11-30 2008-12-01 Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń

Country Status (12)

Country Link
US (1) US8759095B2 (pl)
EP (1) EP2215480B1 (pl)
JP (1) JP5597543B2 (pl)
CN (1) CN101918845B (pl)
AT (1) ATE554396T1 (pl)
BR (1) BRPI0821105A2 (pl)
CA (1) CA2706307C (pl)
DK (1) DK2215480T3 (pl)
ES (1) ES2386231T3 (pl)
PL (1) PL2215480T3 (pl)
PT (1) PT2215480E (pl)
WO (1) WO2009068685A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2215480E (pt) 2007-11-30 2012-07-18 Univ Maastricht Ferramentas de diagnóstico e terapêuticas para doenças que alteram a função vascular
WO2016123163A2 (en) * 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
US10070796B2 (en) 2015-02-04 2018-09-11 General Electric Company Systems and methods for quantitative microcirculation state monitoring
AU2016245994A1 (en) 2015-04-08 2017-11-30 Microvascular Health Solutions, LLC Synergistic glycocalyx treatment compositions and methods
US10449209B2 (en) 2015-04-29 2019-10-22 Arterez, Llc Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
US10507252B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
US10507253B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
WO2018208846A1 (en) * 2017-05-08 2018-11-15 Microvascular Health Solutions, LLC Compositions, systems, and methods for assessing and improving vascular health and treatments involving the same
CN107271348B (zh) * 2017-07-06 2019-11-15 苏州大学 一种医用人造管道渗透性能测试系统及其使用方法
WO2019115724A1 (en) * 2017-12-13 2019-06-20 Valle Brian William Della Biomarkers for multiple sclerosis
CN108681510A (zh) * 2018-05-21 2018-10-19 迈克医疗电子有限公司 数据处理方法及装置
EP3623816A1 (en) 2018-09-12 2020-03-18 GLX Analytix ApS Glx-derived molecule detection
EP3666883A1 (en) * 2018-12-12 2020-06-17 Zhongke Xinray (Suzhou) Biological Technology Co., Ltd. Method and apparatus for screening compounds that have preventive and therapeutic activities against endothelial glycocalyx-related diseases
US11852577B2 (en) * 2021-09-29 2023-12-26 Orange Biomed Ltd., Co. Apparatus for measuring properties of particles in a solution and related methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
JP3566756B2 (ja) * 1993-09-03 2004-09-15 謙 石原 非侵襲血液分析装置とその方法
AU4022801A (en) * 1999-09-23 2001-04-24 Richard G. Nadeau Medical applications of orthogonal polarization spectral imaging
BR0310008A (pt) * 2002-05-09 2005-02-15 Hemoteq Gmbh Preparação, método e uso de revestimentos hemocompatìveis para a prevenção de restenose
CN100479750C (zh) 2003-09-02 2009-04-22 早出广司 葡萄糖传感器和葡萄糖浓度测定装置
US20070225579A1 (en) 2004-05-14 2007-09-27 Koninklijke Philips Electronics, N.V. Fiber Optic Probe
JP2007054483A (ja) 2005-08-26 2007-03-08 Olympus Corp 装着型顕微鏡システム
WO2007075388A2 (en) * 2005-12-15 2007-07-05 X-Cell Medical Incorporated Methods of locally treating and preventing cardiac disorders
PT2215480E (pt) 2007-11-30 2012-07-18 Univ Maastricht Ferramentas de diagnóstico e terapêuticas para doenças que alteram a função vascular

Also Published As

Publication number Publication date
ATE554396T1 (de) 2012-05-15
ES2386231T3 (es) 2012-08-14
US8759095B2 (en) 2014-06-24
JP5597543B2 (ja) 2014-10-01
WO2009068685A1 (en) 2009-06-04
CN101918845A (zh) 2010-12-15
CN101918845B (zh) 2014-01-29
JP2011507560A (ja) 2011-03-10
DK2215480T3 (da) 2012-07-30
US20100304424A1 (en) 2010-12-02
BRPI0821105A2 (pt) 2015-10-06
EP2215480A1 (en) 2010-08-11
EP2215480B1 (en) 2012-04-18
CA2706307C (en) 2017-01-17
CA2706307A1 (en) 2009-06-04
PT2215480E (pt) 2012-07-18

Similar Documents

Publication Publication Date Title
PL2215480T3 (pl) Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
CY1112912T1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
MX345044B (es) Métodos para el diagnóstico de trastornos oncológicos usando cambiadores epimetabólicos, moléculas intracelulares multidimensionales o influenciadores ambientales.
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
GB0515353D0 (en) Food
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
ECSP11011496A (es) Inmunoglobulinas de dominio variable dual y usos de las mismas
MX2009006651A (es) Antagonistas de activina-actrii y usos para incrementar los niveles de globulos rojo.
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
AU324652S (en) Vehicle
BRPI1015967A2 (pt) "unidade de dobradiça, e, peça de mobília."
AU329027S (en) Diagnostic device
AU324636S (en) Dishes
FR2924118B1 (fr) Fragments d'anticorps inhibiteurs de la proteine nef du vih.
AU323419S (en) Teething device
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
NO20091386L (no) Fenyloksyanilinderivater
GB0508988D0 (en) Organic compounds
DK2250190T3 (da) Optimerede adhæsinfragmenter og tilsvarende nanopartikler,
WO2009098029A3 (de) Wundversorgungsartikel
TR201102540U (tr) Hidrolik ayaklı yaşam konteyneri.
WO2010132708A3 (en) Modulation of terminase activity at telomeres and dna double-strand breaks